FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017832304> ?p ?o ?g. }

• W2017832304 endingPage "22865" @default.
• W2017832304 startingPage "22859" @default.
• W2017832304 abstract "Prenylcysteine methyl esters that represent the C-terminal structures of prenylated proteins demonstrate specific substrate-like interactions with P-glycoprotein (Zhang, L., Sachs, C. W., Fine, R. L., and Casey, P. J.(1994) J. Biol. Chem. 269, 15973-15976). The simplicity of these compounds provides a unique system for probing the structural specificity of P-glycoprotein substrates. We have further assessed the structural elements of prenylcysteines involved in the interaction with P-glycoprotein. Carboxyl group methylation, a modification in many prenylated proteins, plays an essential role of blocking the negative charge at the free carboxylate. Substitution of the methyl ester with a methyl amide or simple amide does not change the ability of the molecule to stimulate P-glycoprotein ATPase activity, but substitution with a glycine is not tolerated unless the carboxyl group of glycine is methylated. The presence of a nitrogen atom, which is found in many P-glycoprotein substrates and modifiers, is also essential for prenylcysteines to interact with P-glycoprotein. The structure at the nitrogen atom can, however, influence the type of interaction. Acetylation of the free amino group of prenylcysteine results in a significant loss in the ability of prenylcysteines to stimulate P-glycoprotein ATPase activity. Instead, certain acetylated prenylcysteines behave as inhibitors of this activity. In studies using MDR1-transfected human breast cancer cells, the acetylated prenylcysteine analogs inhibit P-glycoprotein-mediated drug transport and enhance the steady-state accumulation of [3H]vinblastine, [3H]colchicine, and [3H]taxol. These inhibitors do not, however, affect drug accumulation in parental cells. These studies provide a novel approach for designing P-glycoprotein inhibitors that could prove effective in reversing the phenotype of multidrug resistance in tumor cells. Prenylcysteine methyl esters that represent the C-terminal structures of prenylated proteins demonstrate specific substrate-like interactions with P-glycoprotein (Zhang, L., Sachs, C. W., Fine, R. L., and Casey, P. J.(1994) J. Biol. Chem. 269, 15973-15976). The simplicity of these compounds provides a unique system for probing the structural specificity of P-glycoprotein substrates. We have further assessed the structural elements of prenylcysteines involved in the interaction with P-glycoprotein. Carboxyl group methylation, a modification in many prenylated proteins, plays an essential role of blocking the negative charge at the free carboxylate. Substitution of the methyl ester with a methyl amide or simple amide does not change the ability of the molecule to stimulate P-glycoprotein ATPase activity, but substitution with a glycine is not tolerated unless the carboxyl group of glycine is methylated. The presence of a nitrogen atom, which is found in many P-glycoprotein substrates and modifiers, is also essential for prenylcysteines to interact with P-glycoprotein. The structure at the nitrogen atom can, however, influence the type of interaction. Acetylation of the free amino group of prenylcysteine results in a significant loss in the ability of prenylcysteines to stimulate P-glycoprotein ATPase activity. Instead, certain acetylated prenylcysteines behave as inhibitors of this activity. In studies using MDR1-transfected human breast cancer cells, the acetylated prenylcysteine analogs inhibit P-glycoprotein-mediated drug transport and enhance the steady-state accumulation of [3H]vinblastine, [3H]colchicine, and [3H]taxol. These inhibitors do not, however, affect drug accumulation in parental cells. These studies provide a novel approach for designing P-glycoprotein inhibitors that could prove effective in reversing the phenotype of multidrug resistance in tumor cells." @default.
• W2017832304 created "2016-06-24" @default.
• W2017832304 creator A5009620598 @default.
• W2017832304 creator A5011967890 @default.
• W2017832304 creator A5063882299 @default.
• W2017832304 creator A5082625155 @default.
• W2017832304 creator A5090606294 @default.
• W2017832304 date "1995-09-01" @default.
• W2017832304 modified "2023-09-28" @default.
• W2017832304 title "Characterization of Prenylcysteines That Interact with P-glycoprotein and Inhibit Drug Transport in Tumor Cells" @default.
• W2017832304 cites W131157789 @default.
• W2017832304 cites W1485176492 @default.
• W2017832304 cites W1492490882 @default.
• W2017832304 cites W1502426706 @default.
• W2017832304 cites W1527774170 @default.
• W2017832304 cites W1608409978 @default.
• W2017832304 cites W1966162609 @default.
• W2017832304 cites W1981456040 @default.
• W2017832304 cites W1981655068 @default.
• W2017832304 cites W1996878563 @default.
• W2017832304 cites W2037085464 @default.
• W2017832304 cites W2051143903 @default.
• W2017832304 cites W2082064626 @default.
• W2017832304 cites W2082497364 @default.
• W2017832304 cites W2085672600 @default.
• W2017832304 cites W2088693217 @default.
• W2017832304 cites W2097878215 @default.
• W2017832304 cites W2103309735 @default.
• W2017832304 cites W2112001901 @default.
• W2017832304 cites W2118234018 @default.
• W2017832304 cites W2162097287 @default.
• W2017832304 cites W2168070336 @default.
• W2017832304 cites W2168095256 @default.
• W2017832304 cites W2170734806 @default.
• W2017832304 cites W2172134989 @default.
• W2017832304 cites W2178557511 @default.
• W2017832304 cites W2952947579 @default.
• W2017832304 cites W4293247451 @default.
• W2017832304 doi "https://doi.org/10.1074/jbc.270.39.22859" @default.
• W2017832304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7559420" @default.
• W2017832304 hasPublicationYear "1995" @default.
• W2017832304 type Work @default.
• W2017832304 sameAs 2017832304 @default.
• W2017832304 citedByCount "35" @default.
• W2017832304 countsByYear W20178323042013 @default.
• W2017832304 crossrefType "journal-article" @default.
• W2017832304 hasAuthorship W2017832304A5009620598 @default.
• W2017832304 hasAuthorship W2017832304A5011967890 @default.
• W2017832304 hasAuthorship W2017832304A5063882299 @default.
• W2017832304 hasAuthorship W2017832304A5082625155 @default.
• W2017832304 hasAuthorship W2017832304A5090606294 @default.
• W2017832304 hasBestOaLocation W20178323041 @default.
• W2017832304 hasConcept C104317684 @default.
• W2017832304 hasConcept C108625454 @default.
• W2017832304 hasConcept C119157956 @default.
• W2017832304 hasConcept C133936738 @default.
• W2017832304 hasConcept C178790620 @default.
• W2017832304 hasConcept C185592680 @default.
• W2017832304 hasConcept C2778565081 @default.
• W2017832304 hasConcept C2778707650 @default.
• W2017832304 hasConcept C2780263894 @default.
• W2017832304 hasConcept C501593827 @default.
• W2017832304 hasConcept C55493867 @default.
• W2017832304 hasConcept C71240020 @default.
• W2017832304 hasConceptScore W2017832304C104317684 @default.
• W2017832304 hasConceptScore W2017832304C108625454 @default.
• W2017832304 hasConceptScore W2017832304C119157956 @default.
• W2017832304 hasConceptScore W2017832304C133936738 @default.
• W2017832304 hasConceptScore W2017832304C178790620 @default.
• W2017832304 hasConceptScore W2017832304C185592680 @default.
• W2017832304 hasConceptScore W2017832304C2778565081 @default.
• W2017832304 hasConceptScore W2017832304C2778707650 @default.
• W2017832304 hasConceptScore W2017832304C2780263894 @default.
• W2017832304 hasConceptScore W2017832304C501593827 @default.
• W2017832304 hasConceptScore W2017832304C55493867 @default.
• W2017832304 hasConceptScore W2017832304C71240020 @default.
• W2017832304 hasIssue "39" @default.
• W2017832304 hasLocation W20178323041 @default.
• W2017832304 hasOpenAccess W2017832304 @default.
• W2017832304 hasPrimaryLocation W20178323041 @default.
• W2017832304 hasRelatedWork W1483266284 @default.
• W2017832304 hasRelatedWork W1965975410 @default.
• W2017832304 hasRelatedWork W2009936943 @default.
• W2017832304 hasRelatedWork W2120315712 @default.
• W2017832304 hasRelatedWork W2128175049 @default.
• W2017832304 hasRelatedWork W2139303052 @default.
• W2017832304 hasRelatedWork W2383803137 @default.
• W2017832304 hasRelatedWork W2398804374 @default.
• W2017832304 hasRelatedWork W2400355270 @default.
• W2017832304 hasRelatedWork W2949474274 @default.
• W2017832304 hasVolume "270" @default.
• W2017832304 isParatext "false" @default.
• W2017832304 isRetracted "false" @default.
• W2017832304 magId "2017832304" @default.
• W2017832304 workType "article" @default.